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ABSTRACT
Chemical cross-linking mediated by short bifunctional reagents has been widely used for
determining physical relationships among polypeptides in multi-subunit proteins, but less often
for functional studies. Here we introduce the approach of tethering polypeptides by using
bifunctional reagents containing a lengthy, flexible PEG linker as a form of cross-linking
especially suited to functional analyses. The rotary molecular motor ATP synthase was used as a
model subject. Single cysteine residues were introduced into selected positions of ATP synthase
 subunit, a component of the rotor subcomplex of the enzyme, and the unrelated maltose
binding protein (MBP), then the two purified recombinant proteins were cross-linked by means
of a dimaleimido-PEG cross-linking agent.
Following purification, the -PEG-MBP was
incorporated into membrane-bound ATP synthase by reconstitution with -depleted F1-ATPase
and membrane vesicles that had been stripped of endogenous F1. ATP synthase reconstituted
using -PEG-MBP had reduced ATP hydrolytic activity that was uncoupled from the pumping of
H+, indicating the physical blockage of rotation of the c10 rotor by the conjugated MBP,
whereas enzyme reconstituted with -PEG was normal. These results directly demonstrate the
feasibility of studying mechanistic features of molecular motors through PEG-based conjugation
of unrelated proteins. Since tethering polypeptides provides a means of maintaining proximity
without directly specifying or modifying interactions, application of the general method to other
types of protein functional studies is envisioned.
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INTRODUCTION
Chemical cross-linking has been used for many years for the structural analysis of
multisubunit proteins, as it provides a probe of subunit stoichiometry and arrangement.1-5 The
methodology has continually developed, and applications of this type are again resurgent as
methods for rapidly identifying sites of cross-linking through fragmentation coupled with mass
spectrometric analysis are improved.6,7. Chemical cross-linking has also been used for
stabilizing proteins, for altering their solubilities, for targeting them to specific sites, and in some
cases for basic functional analysis.3,8-11 Examples of the latter application include trapping an
intermediate state in a conformational change,12 restricting the ability of a polypeptide to adopt
more than one of multiple known conformational states,13 preventing major subunit
rearrangements,14,15 for creating a dual-function protein16 or for investigating the location of
active sites in an enzyme.17,18 The potential for using chemical cross-linking to investigate
function has been substantially increased by the use of site-directed mutagenesis to direct one
end of the reagent to a specific site and to reduce the possibility of modifying multiple sites.
Nevertheless, the use of traditional short bifunctional reagents for functional analyses is limited
by their potential for severely restricting normal protein dynamics and introducing steric
hindrance to important interactions. The goal of the current project was to cross-link
polypeptides in a manner that would be unlikely to compromise subunit interactions,
conformational changes or otherwise interfere with function through direct mechanisms. To
achieve this we used a bifunctional reagent, dimaleimidyl-PEG1, with a flexible linker containing
about 75 ethylene glycol units.
The subject of our study is Escherichia coli ATP synthase (Figure 1), a membrane-bound
multi-subunit enzyme that couples the energy stored in a transmembrane proton gradient to the
synthesis of ATP from the precursors ADP and Pi. ATP synthase is composed of two molecular
motors that work together in an unusual rotational coupling mechanism. See recent reviews.19-22
The enzyme can be physically separated into a membrane-peripheral F1 sector, an ATP-driven
motor composed of five different polypeptides in a stoichiometry of 33, and the
membrane-integral F0 sector, an ion flux-driven motor composed of three different subunits with
a stoichiometry of ab2c10. The  and  subunits of F1 rotate relative to 33 during ATP
hydrolysis/synthesis, while the c10 ring rotates relative to ab2 as protons cross the membrane.
The c10 subassembly acts as a joint rotor, held together by non-covalent interactions, so that
either motor can drive the other in reverse. A peripheral stator stalk composed of b2 links the
sectors to prevent 33 from simply rotating along with c10 during proton flow.
Previously we engineered forms of ATP synthase with unrelated polypeptides fused to
either the N- or C-terminus of 23,24 Since turning the rotor would require dragging the fused
protein "cargo" through the small port between  and b2 (see Fig. 1A), we expected such fusions
to produce an enzyme lacking significant ATP synthetic or hydrolytic activity. We found that
the port can accommodate a C-terminally fused protein with dimensions 23 X 24 X 48 Å, but not
proteins that are 24 X 37 X 48 Å or 30 X 35 X 55 Å in size.24 The inability of the larger
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constructs to allow growth on nonfermentable carbon sources indicated a lack of oxidative
phosphorylation, supporting operation of the rotational mechanism in vivo.
Surprisingly,
however, membrane vesicles prepared from all such forms retained significant hydrolytic
activity. This residual activity was completely uncoupled from proton pumping, suggesting that
coupling in the enzyme is intrinsically loose. The fusion proteins, however, might perturb the
normal interactions of the terminal segments of  in the enzyme complex and thus could be the
source of the uncoupling. To broaden the range of positions where the added protein "cargo"
might be attached, we have taken a chemical cross-linking approach to tether the 40-kDa (36 X
40 X 63 Å) maltose binding protein (MBP) to  at a different location where effects on the ability
of the polypeptide to interact with other parts of the enzyme are unlikely. By cross-linking MBP
to  through a long flexible PEG-based linker, rotation and proton pumping have been blocked,
while again the enzyme retained substantial uncoupled ATPase activity. We believe that this
methodology of cross-linking through flexible and lengthy linkers will be useful in investigating
mechanistic features of other proteins, including molecular motors and reversibly associating
complexes.
MATERIALS AND METHODS
General methods and reagents
A PEG-based cross-linker (average molecular weight of 3,400 Da) containing maleimide
groups on each end (Mal-PEG-Mal), was purchased from Nektar (San Carlos, CA). Aqueous
stocks containing 25 mM Mal-PEG-Mal were made in ddH2O. All other laboratory chemicals
were of the highest grade. Recombinant DNA techniques were performed by standard methods.
Protein determinations were performed using the Bradford method25 for soluble proteins, and by
the Lowry method26 for membrane samples. SDS-PAGE was carried out using 15% separating
gels with the Laemmli buffer system27, and gels were stained using Coomassie Brilliant Blue R250. Western blotting to polyvinylidene difluoride membranes was performed using the
carbonate buffer system,28 and probed with antibodies that were labeled with 125I using the
IODO-GEN method.29 The anti- monoclonal antibody (-1) has been described.30,31 The anti-
monoclonal antibody (-II)32,33 was a generous gift from Drs. Robert Aggeler and Rod Capaldi
of the University of Oregon. Preparation of E. coli inner membrane vesicles depleted of F1ATPase, as well as measurements of ATP hydrolysis, H+-pumping, and  inhibition were
performed as described by Cipriano et al.24 The unc deletion mutant strain DK8,34 carrying a
plasmid encoding an inactive but properly assembled ATP synthase due to an R376A point
mutation, was used for preparation of the F1-depleted membranes. This plasmid was kindly
provided by Dr. Robert Nakamoto of the University of Virginia.
Plasmid construction and mutagenesis
Plasmid pLH135 encoding wild type maltose binding protein was the parent used for
construction of MBP containing a single, surface-exposed cysteine residue. An A21C
substitution was introduced using polymerase chain reaction with mutagenic primers. The 5’ end
of the MBP coding sequence was amplified using primers GCAACATTCATGATGGG and
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GACCTGCTTCACAGAGACCGTTATAGCC (mutagenic codon underlined) and cut with
PflMI
and
BsaI.
The
3’
end
was
amplified
using
primers
GCAGGGTCTCTGTGAAGTCGGTAAGAAATTCGAG (mutagenic codon underlined) and
GTCTTTAATGTCGCCATACTTGAACGCATAACCCCCGTC and cut with BsaI and BsiWI.
These two DNA fragments were ligated into pLH1 that had been linearized with PflMI and
BsiWI in a three-part ligation to produce pDC37. Plasmid pES236, encoding wild type  was
the parental plasmid for the H56C mutation. The PCR product obtained using primers
CTGGTATGATTCGCATCGTGAAACAGTGCGGTCACGAAGAG
(mutagenic
codon
underlined) and GCGATGTAACACCGGCTTGA was cut with BsaBI and SgfI and ligated into
pES2 that had been cut with the same enzymes to produce pSD174. Plasmid constructions were
confirmed by restriction endonuclease mapping and DNA sequencing.
Protein purification
H56C was expressed from pSD174 in E. coli strain MM29437 and the growth and
purification was performed as described for wild type 24, except that 1 mM DTT was included
in buffers. MBPA21C was expressed from pDC37 in strain HS330935 at 37 C with vigorous
shaking in 1 liter of 2xYT media until cultures reached stationary phase. Periplasmic proteins
were extracted by osmotic shock,38 dialyzed into 50 mM Tris-HCl, pH 8.0, 1 mM DTT and
loaded onto a 35-ml column of DEAE Sepharose Fast Flow (GE Healthcare). The column was
washed with 5 volumes of 50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT, and eluted with
a 0-500 mM linear gradient of NaCl in 8 column volumes of the same buffer. Fractions
containing MBPA21C were pooled, concentrated, and subjected to gel filtration chromatography
using a Sephacryl S200 (GE Healthcare) column that had been equilibrated with 50 mM TrisHCl, pH 8.0, 1 mM EDTA, 1 mM DTT.
To obtain -depleted F1-ATPase, we first purified F1-ATPase containing an N-terminally
fused and C-terminally truncated form of , CBD-88-stop, expressed from pDC4623 in DK834
cells, using described methods.31 -depleted F1 was prepared essentially as described39 but using
F1 containing CBD-88-stop as the starting material and a chitin affinity column in place of the
immunoaffinity column containing the -4 monoclonal antibody.
Synthesis and purification of -PEG-MBP
Two samples, one containing 22 ml of 73 M H56C, and another containing 22 ml of 73
M MBPA21C, were independently reduced with 1 mM DTT and dialyzed against 2 litres of 10
mM MOPS-NaOH, pH 7.0, 1 mM EDTA. After 8 hours the buffer was changed and the samples
were dialyzed against an additional 2 litres for a further 10 hours. An aliquot of each was
removed and diluted into SDS-gel sample buffer containing 15 mM N-ethylmaleimide (NEM)
and saved for SDS-PAGE analysis. The two samples were mixed, and an additional aliquot was
removed and treated with NEM for SDS-PAGE. Cross-linking was performed at room
temperature by the addition of Mal-PEG-Mal to 36.6 M in 10 equal aliquots, with 2 minutes
between successive additions. The reaction was incubated at room temperature for 2 hours
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before addition of 1 mM NEM to block any remaining thiol groups. Finally, 10 mM mercaptoethanol was added to quench any residual maleimide groups.
-PEG-MBP was purified from the product mixture using two consecutive
precipitations with 80% saturated ammonium sulfate. The final pellet was suspended in 50 mM
HEPES-KOH, pH 7.0, 1 mM EDTA, 50 mM NaCl, and the remaining ammonium sulfate was
removed by dialysis into the same buffer. The sample was then loaded onto a column containing
5 grams of hydroxylapatite (Biorad), and eluted with a linear gradient of 0-200 mM sodium
phosphate, pH 7.0. As controls,  cross-linked to only a PEG molecule, and  labeled with NEM
were also prepared. A 10-fold excess of the Mal-PEG-Mal cross-linker was added to H56C alone
and quenched with -mercaptoethanol to produce -PEG. The -PEG was then purified from
unreacted H56C and -PEG- using DEAE anion exchange chromatography.
Reconstitution of  constructs into ATP synthase
150 g of -depeleted F1 and 7.5 g of purified  were mixed with either 6 g of , NEM, -PEG, or with 21.7 g of -PEG-MBP in a total volume of 200 l of 50 mM HEPESKOH, pH 7.5, 5 mM MgCl2, 300 mM KCl. After incubation at 37 °C for 10 minutes, 3 mg of
stripped membrane vesicles were added, followed by an additional 10 minute incubation at 37
°C. The sample was then diluted into 10 ml of 10 mM MOPS-NaOH, pH 7.5, 250 mM sucrose,
5 mM MgCl2, 10% methanol, and centrifuged for 1.5 hours at 38,000 RPM in a Beckman 50-Ti
rotor. The resultant pellet was suspended in 200l of the same buffer by gentle homogenization.
RESULTS
Strategy for blocking rotation
Previous attempts to block rotation in ATP synthase by genetically fusing large
polypeptides to either the N-23 or the C-terminus24 of  resulted in the uncoupling of residual
ATP hydrolysis from proton pumping. These findings implied that either the ATP synthase is
naturally partially uncoupled, or else that the added protein masses at the extreme ends of the 
molecule perturbed its natural structure and/or function, resulting in uncoupling. Here we
overcame the limitation of fusion at only the ends of the polypeptide chain by taking a chemical
approach to tether a large globular protein to a position internal in the  sequence, but at the
periphery of the protein structure (Figure 1), so that effects on the structure, function, or
interactions of  are unlikely.
The overall approach, outlined in Figure 1B, was to cross-link  to the 40-kDa maltose
binding protein (MBP) of E. coli in vitro, then to use the known biochemical properties of ATP
synthase to reconstitute cross-linked  back into the membrane-bound enzyme. To achieve
cross-linking through specific sites, cysteine residues were introduced by site-directed
mutagenesis into specifically chosen positions of the two polypeptides, neither of which contain
endogenous cysteines.  residue His-56 was chosen as the site for chemical linkage because in
the bovine F1 crystal structure40 the corresponding residue of the homologous subunit is farremoved from other subunits (Figure 1C), and it has previously been mutated to cysteine and
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labeled with maleimide fluorophores with no apparent effect on function.41 Utilizing the high
resolution structure of MBP42 we selected the surface-exposed position Ala-21 of the mature
protein. Following expression and purification, the polypeptides were cross-linked using 3.4
kDa Mal-PEG-Mal, a cross-linker with maleimido moieties on each end of a PEG chain that
contained on average 75 ethylene glycol units, providing a 250-Å tether between the proteins.
Synthesis, purification and inhibitory activity of -PEG-MBP
Plasmid-borne H56C and MBPA21C were expressed in E. coli and purified using standard
methods. Cross-linking of a mixture of the two proteins using Mal-PEG-Mal was carried out as
described under Experimental Procedures, yielding a mixture of seven different protein species:
MBP-PEG-MBP, -PEG-MBP, MBP-PEG, unreacted MBP, -PEG-, -PEG, and unreacted 
(Figure 2A). Assignment of the bands was based on apparent molecular weights and by
comparison to products seen in control reactions in which only one of the proteins was treated
with Mal-PEG-Mal.
The -PEG-MBP was purified from the mixture utilizing differences in the solubility and
adsorption to hydroxylapatite as described under Experimental Procedures. This and other
forms of  used for reconstitution of the ATP synthase are shown on the SDS-PAGE in Figure
2B. A small amount of MBP-PEG remained in the -PEG-MBP sample, but this would not be
expected to interfere with the reconstitution of -PEG-MBP into the ATP synthase. Control
proteins used in the studies included H56C that was reacted with an excess of N-ethylmaleimide
to modify the cysteine residue (-NEM), and H56C that was labeled with a single PEG molecule
(-PEG) and purified by DEAE chromatography.
One concern with any method of adding one protein to another is that the added protein
may alter the normal interactions of the targeted protein. Since  is a dissociable inhibitor of
ATP hydrolysis by soluble F1,43 we determined the effect of the PEG-MBP linkage on this
functional property. It should be noted that the mechanism by which  subunit inhibits ATP
hydrolysis by isolated F1 is quite different from that outlined in Figure 1A, as it depends on
direct interactions of its C-terminal domain with 3343-45 and is independent of the peripheral
stalk. The wild type  and -PEG-MBP forms inhibited ATPase activity to similar extents and
with similar affinities (Figure 2C), indicating that cross-linking H56C to MBPA21C with Mal-PEGMal did not perturb the normal interactions of  with F1. In contrast, previous results showed
that fusing globular proteins to the C-terminus of , even through a linking peptide, completely
abolished this inhibition,24 implying that the C-terminal fusions did perturb the normal
interactions of the C-terminal domain of  with 33
Reconstitution of -PEG-MBP into ATP synthase
The ATP synthase reconstitution procedure (Figure 1B) takes advantage of the facts that
F1 reversibly dissociates from the membrane-embedded F0 under conditions of low-ionic
strength46 and that  is bound reversibly to F1 such that it can be removed and replaced.43 A
previously described method to produce -depleted F139 using anti- immunoaffinity
chromotography was adapted here using an F1-ATPase carrying a C-terminally truncated form of
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the  subunit fused N-terminally to a chitin binding domain (CBD-88-stop).23 The CBD acts as an
affinity tag, allowing the substitution of a chitin column for the anti -4 immunoaffinity column
originally used in the -depletion procedure39 while the C-terminal deletion is expected to reduce
the affinity of  for F1. As seen in Figure 2D, the chitin column effectively removed the CBD88-stop (apparent molecular weight 16 kDa) from F1. This procedure provides a method for
depleting F1-ATPase of  without the need for monoclonal antibodies, and could be adapted to
remove any protein subunit that reversibly dissociates from a multi-subunit protein complex.
Incubation of membrane bacterial vesicles in buffer of low ionic strength lacking Mg2+
releases the F1 sector of ATP synthase, leaving the membrane-integral F0 sector in these F1depleted, or "stripped", vesicles. The enzyme may be reconstituted by incubation of the stripped
vesicles with added F1-ATPase in the presence of Mg2+; this reconstitution depends on both the 
and  subunits.47,48 During the  depletion procedure, the  subunit was degraded (Figure 2D),
giving rise to the ' fragment (residues 1-134) described previously;49,50 intact recombinant 51
was therefore added to mediate reconstitution. After assembly of the various  constructs into
F1, and rebinding F1 to membrane-bound F0, the vesicles were subjected to a wash step to
remove any unbound F1, and then analyzed for assembly of ATP synthase complexes by assaying
for ATPase activity (Table 1) and by western blotting using antibodies against the  and 
subunits (Figure 3A).
Reconstituted membrane samples were assayed for ATP hydrolysis activity in two
24
ways . In the "Membrane-bound ATPase" assay, samples are continually in the presence of
Mg2+, which maintains the integrity of ATP synthase in the membranes. In the "Released
ATPase" assay, the membranes are initially diluted into Mg2+-free, low ionic strength buffer,
promoting the release of F1 from membrane-integral F0. Due to the high level of dilution,
subunit dissociates from F1 and the enzyme reaches its maximal activity, providing a measure
of the total amount of F1 in the sample. We call the ratio of membrane-bound to released activity
the "normalized activity"; for wild-type ATP synthase the normalized activity is in the range of
0.4-0.5, reflecting differences between the assays in conditions and the modest inhibitory effect
of the  subunit within intact ATP synthase. Blockage of rotation (Fig. 1A) specifically affects
the ATPase activity of the membrane-bound enzyme, resulting in lower normalized activity.23,24
For these reconstitution reactions we used stripped membranes prepared from a strain
carrying the catalytically inactive R376A mutant52 so that any residual F1 would not contribute
to measured activities. The stripped membranes contained only 0.01 to 0.02 U of ATPase
activity per mg of protein (see Table 1, footnote b). The low level of  seen by western blot in
the sample reconstituted with only -depleted F1 (Figure 3A) reflects traces of residual, inactive
ATPase from the membranes, since any remaining  in the -depleted F1 would be the larger
CBD-88-stop construct. A low level of F1 was bound independently of , as seen by the modestly
higher level of  subunit, relative to , in the sample reconstituted with -depleted F1. This independent F1 binding (less than 0.3 U of ATPase per mg of membrane protein, see Table 1,
footnote c) was about one quarter of the -dependent binding seen in the other samples. The
8

nonspecific nature of the binding seen in the absence of  is also reflected by the high (>0.8)
normalized activity of this sample.
Membranes reconstituted with F1 containing either -PEG or -PEG-MBP showed levels
of and  similar to controls (Figure 3A) and normal levels of released ATPase activity (Table
1), indicating that the abilities of -PEG and -PEG-MBP to mediate binding of F1 to stripped
membranes were uncompromised. As expected in samples that are blocked in rotation by the
peripheral stalk, the membrane-bound ATPase activity of the -PEG-MBP sample was
specifically suppressed, lowering the normalized activity to 0.21. It is notable, however, that
membranes reconstituted with -PEG-MBP still retained a substantial level of ATP hydrolysis,
as previously seen with samples bearing large N-terminal  fusions.23
Proton pumping is blocked by tethered MBP
The reconstituted membrane vesicles were assayed for ATP-dependent proton pumping
as a measure of the coupled state of the enzyme (Figure 3B). In this assay, the quenching of
fluorescence of ACMA, which is accumulated by the vesicles in response to a proton gradient, is
monitored to provide a semiquantitative indication of the ATP-dependent pumping of protons
into the lumen of the vesicles. Subsequent addition of FCCP, an uncoupler that dissipates the
proton gradient and allows redistribution of ACMA across the membrane, distinguishes
quenching due to vesicular uptake from that attributable to direct quenching by nucleotides. As
seen in Figure 3B (upper panel), vesicles reconstituted with wild-type F1-ATPase (trace c)
exhibited typical ATP-dependent proton pumping, while the stripped vesicles, or those with the
non-specifically bound -depleted F1, did not. In Figure 3B (lower panel) it can be seen that
when the -depleted F1 was mixed with either wild-type , -NEM, or -PEG, to promote
reconstitution onto membranes, proton pumping was restored. These results indicate that neither
simple modification of position 56 nor attachment of the lengthy PEG chain to that position
directly affected function. In contrast, reconstitution with -PEG-MBP failed to restore
discernible ATP-dependent proton pumping (trace d) despite the significant levels of membranebound ATP hydrolysis (Table 1).
DISCUSSION
In recent work, we have explored the effects of attaching an unrelated globular protein to
the ATP synthase rotor subunit  in such a way that rotational catalysis would be blocked. In
our previous studies polypeptides were fused to the N- or C-termini of  through a recombinant
DNA approach. The gene fusion strategy has many advantages, but the terminal regions of a
polypeptide may have critical functions that could be disrupted by the fusions. In the case of ,
fusions at the C-terminus resulted in high levels of uncoupled ATPase activity, while N-terminal
fusions caused lower, but still significant, levels. In order to confirm that the uncoupled activity
is inherent to rotation-blocked ATP synthase, we considered additional ways to attach the protein
"cargo". Internal protein fusions are possible but difficult,53 and these would seem to be more
likely than terminal fusions to have direct functional consequences.
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We therefore adopted the protein chemical strategy described here. One of the
advantages of this approach is that nearly any surface position can be selected as the site of
attachment. Direct addition of another polypeptide through an intermolecular cystine linkage or
a short cross-linking agent might be expected to directly hinder some aspects of protein function,
such as conformational changes, so we used the lengthy (250 Å) and flexible dimaleimido-PEG.
The validity of this approach was confirmed by the lack of functional impairment of enzyme
reconstituted with  that had bound only the PEG molecule. This control experiment allowed us
to conclude that the functional impairment seen for enzyme reconstituted with -PEG-MBP was
due to the blockage of rotation by MBP. It should be noted that by linking MBP to the ATP
synthase, the effective local concentration of MBP around the synthase will be high. Potentially,
this could interfere with the ATPase activity and coupling, but we feel this possibility to be
unlikely. In vivo, ATP synthase functions despite macromolecular crowding54 that presents the
enzyme with a plethora of proteins and nucleic acids that could also have this effect. The local
MBP concentration is also minimized by using a long linker (250 Å in this case). The fact that
tethering MBP to results in an ATP synthase with the same properties as those in which  was
genetically linked to two non-related proteins23,24 validates this expectation. Together, these
results provide substantial support for our hypothesis that rotation-blocked ATP synthase
possesses residual, uncoupled ATP hydrolysis activity.
It is unclear at this point whether the intrinsic uncoupled ATPase activity we observe
serves a physiological purpose, e.g. in dissipating excessive protonmotive force, or if it reflects
the challenges inherent in achieving a perfectly coupled system. The latter would require the
exact co-ordination of substrate binding, catalysis, product release, rotation, and proton
translocation. As we noted previously,23 an uncoupled event will occur if the rotor turns in the
direction of ATP synthesis when ADP and phosphate are not bound at the active site. In the
chloroplast and mitochondrial ATP synthase, a role for  as a coupling factor has been well
established.55,56 It will be interesting to see if direct observation of this slippage may be possible
using single molecule techniques.57,58 The conformation of the C-terminal domain has been
shown to change in response to different nucleotides59 and a regulatory role has been
proposed.59-61
PEGs are commercially available in various lengths and with a number of different
reactive groups at their ends. Currently, Mal2-PEG reagents can be obtained in 2K, 3.4K, 6K,
8K and 10K molecular weights from SunBio Corporation. Multi-branched PEG derivatives are
also available. One of the major uses of activated PEG reagents is the PEGylation of proteins
that are injected for therapeutic purposes;62-65 PEGylation enhances the lifetimes of such
proteins in vivo, increasing their therapeutic effectiveness. In the current work we required a
reagent to cross-link two proteins through specific, defined sites, so we used mal-PEG-mal,
which reacts specifically with sulfhydril groups at each end. Cysteine is among the least
common of amino acids in most proteins, and here, as in many cases, there were no endogenous
cysteines to remove before engineering them into the sites of our choice. Furthermore, since
cysteine has a relatively hydrophobic sidechain, endogenous cysteines in many proteins are
10

buried rather than on the surface where they would react readily. Nevertheless, due to the
random nature of the cross-linking reaction it was necessary to purify the desired product -PEGMBP from the product mixture. However, increasingly specific ways of modifying proteins, or
of introducing uniquely reactive groups into them, are under ongoing development and we
anticipate that the specificity of cross-linking proteins through such sites will increase in the
future.
CONCLUSION
Elucidating the structure and function of a protein may require application of a wide
range of techniques, each with its own strengths and limitations. Polypeptide fusions are
frequently useful, but may disrupt structure if the terminus is buried in the protein structure, or
may directly affect function, as we saw for the C-terminal  fusions.24 While traditional crosslinking methodology using relatively short spacers has numerous variations that are useful and
appropriate for studies of the spatial relationships of polypeptides, its application to questions of
function have been limited. The use of derivatized PEG molecules for protein cross-linking
offers a number of advantages. The substantial length of the PEG makes localized steric effects
due to the proximity of globular proteins unlikely and avoids the distortion of protein structure
that often accompanies the engineering of disulfide linkages directly between introduced
cysteine residues. The hydrophilic nature of PEG reduces the potential for nonspecific
interactions with protein surfaces. To our knowledge, the method we have developed is novel,
but a number of types of applications can be envisaged. In the present work we have used this
approach to block rotation of the ATP synthase and show that the enzyme is loosely coupled. In
the field of molecular motors, the attachment of cargo molecules to motor proteins can be useful
in studying rotational aspects, as we have done, or in quantifying force generation. More
generally, flexible PEG linkers can maintain physical proximity between two molecules,
fostering their interaction without dictating its molecular details. Ordinarily, then, one would
expect that native-like interactions would be formed. This property makes the technique suitable
for flexibly and artificially linking individually expressed domains so that the functional
importance of the polypeptide linkage normally connecting them might be determined. We also
see general applicability to proteins whose function requires the reversible assembly of
complexes at the site of action, such as type I restriction endonucleases and transcription factor
complexes. Finally, the method could be adapted to tag one subunit of an in vitro-assembled
complex for purposes such as quantitation or affinity isolation.
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Table I. ATPase activity of reconstituted membrane vesiclesa
Additions to reconstitution
Stripped
Membranes

WT F1

depleted
F1

Activity
type

Membranebound
ATPase
activityb,c

Released
ATPase
activityb,c

units/mg

units/mg

Normalized
activityd

+

-

+

None

0.00 ± 0.01

0.00 ± 0.02

N/A

+

+

-

None

0.52 ± 0.02

1.18 ± 0.03

0.44

+

-

+

WT 

0.42 ± 0.01

1.11 ± 0.05

0.38

+

-

+

-NEM

0.50 ± 0.02

1.22 ± 0.02

0.41

+

-

+

-PEG

0.60 ± 0.04

1.63 ± 0.05

0.37

+

-

+

-PEG-MBP

0.24 ± 0.05

1.13 ± 0.02

0.21

a

Membranes vesicles were diluted into ATP hydrolysis assays under conditions that either
maintain F1 bound to membranes or cause its release. Data shown are the average of triplicate
assays  standard deviation. 1 Unit of activity is defined as 1 mol product formed per min.
b

Stripped membranes alone showed 0.02 ± 0.01 and 0.01 ± 0.01 U/mg in the bound and released
assays respectively (uncorrected).
c

Activity values were corrected for background activity of 0.23 U/mg (bound) and 0.28 U/mg
(released) due to unbound F1 detected in the sample reconstituted with only -depleted F1.
d

Membrane-bound activities were normalized to the activity released from membranes and
expressed as the fraction of units bound per unit released.
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Figure 1. Tethering MBP to the rotor of ATP
synthase. Schematic diagram (A) outlines the
subunit composition of ATP synthase and the
strategy employed to block rotation of the c10
rotor (shown in dark grey) by chemically linking the
40-kDa maltose binding protein (MBP) to the 
subunit. Rotation would drag the MBP between
the central and peripheral stalks, but it is too large
to pass through the port. The dimensions of the
enzyme are shown but the drawing is not exactly to
scale. Flow diagram (B) outlines the reconstitution
process to assemble ATP synthase complexes with
-PEG-MBP. Crystal structure (C) of the bovine F1
complex (PDB # 1E79) shows the homologue of
bacterial  in red with residue Glu-69 (the position
homologous to His-56 in the E. coli  sequence) in
grey spacefill. The rotor subunit  is in orange. The
short polypeptide shown in green, located behind ,
is not present in the bacterial enzyme.
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Figure 2. Cross-linking, preparation and characterization of samples. (A) Non-reducing SDSPAGE analysis illustrating the cross-linking of MBP to . Samples of the individual purified
proteins, a mixture at a 1:1 molar ratio before cross-linking, and the product mixture obtained
after cross-linking with the PEG-bis-maleimide reagent are shown. The bands were assigned as:
a, MBP-PEG-MBP; b, -PEG-MBP; c, MBP-PEG; d, unreacted MBP; e, -PEG-; f, -PEG; and
g, unreacted , based on cross-linking experiments using the polypeptides and PEG-bismaleimide at varying ratios (data not shown). (B) The purity of  derivatives prepared in this
study was analyzed by SDS-PAGE. (C) The effect of various concentrations of wild type 
(squares) and -PEG-MBP (circles) on the ATPase activity of F1 was determined. (D) Purified
F1-ATPase containing CBD-88stop (left) was depleted of CBD-88stop by chitin affinity
chromatography (right).
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Figure 3. F1-Depleted membrane vesicles were
reconstituted with either wild-type F1-ATPase
(control) or -depleted F1-ATPase in conjunction
with the indicated -derivatives. (A) Samples of
membrane protein (2 g) carrying reconstituted
ATP synthase were analyzed by western blotting.
Blots were probed with 125I labeled antibodies
specific to  or . (B) ATP-Dependent H+
pumping by reconstituted membranes was
analyzed by ACMA fluroescence quenching. At
the times indicated, ATP was added to 2 mM and
the uncoupler carbonyl cyanide p(trifluoromethoxy)phenylhydrazone (FCCP) was
added to 2 M. Upper Panel: control
experiments with traces representing H+ pumping
by membrane vesicles reconstituted with depleted F1, (a); no F1 (b); and wild-type F1, (c).
Lower Panel: membranes carrying ATP synthase
reconstituted with -depleted F1-ATPase in
conjunction with -PEG-MBP (d); wild-type ,
(e); -NEM, (f); and -PEG, (g).
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